학술논문
BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study
Document Type
Article
Author
Chu, Quincy; Leighl, Natasha B.; Surmont, Veerle; van Herpen, Carla; Sibille, Anne; Markman, Ben; Clarke, Stephen; Juergens, Rosalyn A.; Rivera, Mirelis Acosta; Andelkovic, Vladimir; Rudin, Charles M.; Snow, Stephanie; Kim, Dong-Wan; Sanatani, Michael; Lin, Hongxia; Sanghavi, Kinjal; Tannenbaum-Dvir, Sarah; Basciano, Paul; Lathers, Deanne; Urbanska, Katarzyna; Kollia, Georgia; He, Chunsheng; DiPiero, Andrew; Liu, Yu; Ready, Neal
Source
In JTO Clinical and Research Reports November 2022 3(11)
Subject
Language
ISSN
2666-3643